Back to Directory
biotechnology logo

Parallel Bio | Company Profile

9/23/2025

Contact Information

πŸ‘€
Parallel Bio
🏒
Parallel Bio
πŸ“
750 Main St, Cambridge, Massachusetts 02139, US

Industry & Market

Primary Industry
biotechnology
Location
Cambridge, Massachusetts, United States

Company Metrics

πŸ‘₯Total Employees
11
βš™οΈEngineering
4
πŸ’ΌSales Team
N/A
πŸ“ˆMarketing
N/A
πŸ“…Founded
N/A
πŸ’°Revenue
3.2M

Funding Information

Total Funding
$25.3M
Latest Stage
Series a
Annual Revenue
$3,200,000

Headcount Distribution

Total Employees
11
Departments
19

By Department

Department Breakdown

Engineering
Education
Entrepreneurship
Operations
Human Resources
Accounting

Technology Stack

Analytics & Tracking

Google Tag Manager

Email & Communication

Gmail
Total: 15 technologies

Keywords & Focus Areas

medical researchpredictive drug safetyimmune response outside of patientshuman immune system modelingdisease modelsbiotechnologyimmune system in a dishhigh-throughput automationpersonalized medicineimmune response testingpharmaceuticalspopulation-scale immune dataimmune system replicasai drug discoveryhuman immune responsebioengineeringimmune system in vitroimmune organoidsmachine learningai-powered drug discovery+10 more
30 total keywords

Parallel Bio

Overview

Parallel Bio is a biotechnology company based in Cambridge, Massachusetts, founded in 2021. The company has developed a unique platform that replicates the human immune system in a dish, utilizing human immune organoidsβ€”3D tissue models that mimic the structure and function of human lymph nodes. This innovative approach, combined with artificial intelligence and robotics, aims to enhance drug discovery and development by providing more accurate models of human disease compared to traditional animal testing.

The mission is to transform immunotherapy discovery by replacing animal models with human-derived organoids. This method addresses significant challenges in drug development, as many new drugs fail in clinical trials due to inaccurate predictions from animal testing. The technology seeks to reduce drug development timelines and costs while accelerating the delivery of safer and more effective therapies. Offerings include an Immune Organoid Platform, Trial-in-a-Dish services, patient-matched disease modeling, and target discovery, all designed to improve medication development and outcomes for patients.

Basic Information

Industry Biotechnology
Revenue 3.2M
Headquarters 750 Main St, Cambridge, Massachusetts 02139-3544, United States

Contact Details

Key Focus Areas & Initiatives

  • Medical research
  • Predictive drug safety
  • Immune response outside of patients
  • Human immune system modeling
  • Disease models
  • Biotechnology
  • Immune system in a dish
  • High-throughput automation
  • Personalized medicine
  • Immune response testing
  • Pharmaceuticals
  • Population-scale immune data
  • Immune system replicas
  • AI drug discovery
  • Human immune response
  • Bioengineering
  • Immune system in vitro
  • Immune organoids
  • Machine learning
  • AI-powered drug discovery
  • Trial-in-a-Dish
  • Immune training data
  • Disease modeling
  • B2B
  • Services
  • Research and development in the physical, engineering, and life sciences
  • Predictive analytics
  • Medical
  • Artificial intelligence
  • Information technology & services
  • Enterprise software
  • Enterprises
  • Computer software

Technologies Used

  • Amazon AWS
  • Android
  • Circle
  • Gmail
  • Google Apps
  • Google Tag Manager
  • Greenhouse.io
  • Mobile Friendly
  • NSOne
  • Remote
  • Render
  • Rippling
  • Squarespace ECommerce
  • TikTok
  • Typekit

Affiliated Organizations & Regional Branches

    Need more information?

    Find decision makers, more insights and contact information about this company on Bitscale

    Try Bitscale Now

    Schedule your demo now!

    See how BitScale can supercharge your outbound sales in a 30-minute demo

    SayData

    Β© 2025 Bitscale. Featherflow Technology Pvt Ltd

    LinkedInTwitterInstagramYouTube